secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0001104659-22-000943
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio appoints Megan Smeykal as Chief Accounting Officer effective Jan 1, 2022
--------------------------------------------------------------------------------

- Megan Smeykal, age 46, promoted from VP – Corporate Controller to Chief Accounting Officer.
- She joined TELA Bio in Dec 2019 as VP of Financial Reporting; prior VP at Nutrisystem 2006–2019.
- Started accounting career at Arthur Andersen (1997–2002); holds CPA license in Pennsylvania.
- No family relationships with directors/officers; no transactions requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465922000943/0001104659-22-000943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465922000943/tm2136679d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-000943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer